The government’s funding boost is a step in the right direction. This is how it will help research avoid the ‘valley of death’ which is the place between the lab and marketplace.
Preclinical studies are an important part of biomedical research, often guiding future trials in humans. Failure to replicate research results suggests a need to increase the quality of studies.
Rising temperatures mean longer, earlier pollen seasons, but the bigger problem is what carbon dioxide will do to the amount of pollen being released. A 200% increase is possible this century.
Canada and its universities have roles to play in providing safe spaces to scholars in regions where research is under threat due to conflict and repression.
We’ve all heard an exasperated “do your research!” from people who want to persuade us to accept their claim or point of view. The problem is it’s not likely to convince anyone.
Young people have a right to be engaged, and a right to be heard in research. When young people’s voices are included in the research process, the result is richer and more relevant research evidence.
It’s easy for researchers to fall back on using test subjects from the communities around them – students and employees. Branching out is key to avoiding technology that fails certain populations.
Most of my work takes place in the lab. But recently I became involved with an organisation which allows me to connect with the very people who could one day benefit from my research.
After years of government rhetoric about boosting the commercial benefits from university research, Australia’s record is still among the worst in the developed world.
The Morrison government is pushing for universities to shift focus to commercialising their research, announcing $242.7 million for a yet-to-be-selected small group of “trailblazer” universities
Previous Vice President of the Academy of Science of South Africa and DSI-NRF SARChI chair in Fungal Genomics, Professor in Genetics, University of Pretoria, University of Pretoria